Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy L Olson

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Chest|December 15, 2006
A 63-year-old man with a persistent pulmonary infiltrate and pleural effusionAmy L Olson, Gregory P Cosgrove, Kevin K Brown, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 23, 2018
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotypeAmy L Olson, Alex H Gifford, Naohiko Inase, et al.
Respiratory Medicine|May 5, 2018
The impact of carrying supplemental oxygen on exercise capacity and dyspnea in patients with interstitial lung diseaseDeepa Ramadurai, Maeveen Riordan, Bridget Graney, et al.
Advances in Therapy|June 22, 2021
Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database AnalysisAmy L Olson, Padmaja Patnaik, Nadine Hartmann, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 5, 2013
Scleroderma lung diseaseJoshua J Solomon, Amy L Olson, Aryeh Fischer, et al.
Journal of Managed Care & Specialty Pharmacy|February 3, 2024
Health care costs and utilization of progressive fibrosing lung disease by underlying interstitial lung disease typeMona Nili, Andrea Steffens, Amy Anderson, et al.
Lung|May 27, 2026
Workplace Productivity Loss in Patients with Progressive Pulmonary Fibrosis: Data from the ILD-PRO RegistrySharashchandra Shetty, Aparna C Swaminathan, Peide Li, et al.
Expert Review of Respiratory Medicine|April 7, 2015
Physical functional capacity in idiopathic pulmonary fibrosis: performance characteristics of the continuous-scale physical function performance testAmy L Olson, Jeffrey J Swigris, Amanda Belkin, et al.
Respirology (Carlton, Vic.)|October 16, 2010
Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosisJeffrey J Swigris, Amy L Olson, Oksana A Shlobin, et al.
Respiratory Research|February 28, 2025
Supplemental oxygen therapy use among patients with fibrosing interstitial lung disease in the United StatesJoseph Yang, Andrea Steffens, Amy L Olson, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Chest|December 15, 2006
A 63-year-old man with a persistent pulmonary infiltrate and pleural effusionAmy L Olson, Gregory P Cosgrove, Kevin K Brown, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 23, 2018
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotypeAmy L Olson, Alex H Gifford, Naohiko Inase, et al.
Respiratory Medicine|May 5, 2018
The impact of carrying supplemental oxygen on exercise capacity and dyspnea in patients with interstitial lung diseaseDeepa Ramadurai, Maeveen Riordan, Bridget Graney, et al.
Advances in Therapy|June 22, 2021
Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database AnalysisAmy L Olson, Padmaja Patnaik, Nadine Hartmann, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 5, 2013
Scleroderma lung diseaseJoshua J Solomon, Amy L Olson, Aryeh Fischer, et al.
Journal of Managed Care & Specialty Pharmacy|February 3, 2024
Health care costs and utilization of progressive fibrosing lung disease by underlying interstitial lung disease typeMona Nili, Andrea Steffens, Amy Anderson, et al.
Lung|May 27, 2026
Workplace Productivity Loss in Patients with Progressive Pulmonary Fibrosis: Data from the ILD-PRO RegistrySharashchandra Shetty, Aparna C Swaminathan, Peide Li, et al.
Expert Review of Respiratory Medicine|April 7, 2015
Physical functional capacity in idiopathic pulmonary fibrosis: performance characteristics of the continuous-scale physical function performance testAmy L Olson, Jeffrey J Swigris, Amanda Belkin, et al.
Respirology (Carlton, Vic.)|October 16, 2010
Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosisJeffrey J Swigris, Amy L Olson, Oksana A Shlobin, et al.
Respiratory Research|February 28, 2025
Supplemental oxygen therapy use among patients with fibrosing interstitial lung disease in the United StatesJoseph Yang, Andrea Steffens, Amy L Olson, et al.
Pageof 6